Comparative in vitro studies of nalidixic acid, oxolinic acid, and a new analog with thieno (2,3-b) pyridine structure.
Bacterial susceptibility to a new organic acid related to nalidixic acid and oxolinic acid was tested. The in vitro susceptibility pattern of the new compound was found to be very similar to that of nalidixic acid.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000494:pharmacology*; D009539:Nicotinic Acids / Q000494:pharmacology*; D010093:Oxolinic Acid / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D009539:Nicotinic Acids; D009268:Nalidixic Acid; C050078:7-ethyl-2-methyl-4-oxo-4,7-dihydrothieno(2,3-b)pyridine-5-carboxylic acid; D010093:Oxolinic Acid
J Med Pharm Chem. 1962 Sep;91:1063-5
14056431
Ann Intern Med. 1969 Apr;70(4):713-21
4977045
J Urol. 1970 Dec;104(6):903-13
5532919
J Med Chem. 1968 Jan;11(1):160-3
5637164
N Engl J Med. 1966 Nov 17;275(20):1081-9
5923022